ACLX
Arcellx (ACLX)
$
23About Arcellx (ACLX)
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.
Details
Daily high
$65.91
Daily low
$63.70
Price at open
$64.20
52 Week High
$107.37
52 Week Low
$47.88
Market cap
3.5B
Dividend yield
0.00%
Volume
246
Avg. volume
601,829
P/E ratio
-87.46
Arcellx News
Details
Daily high
$65.91
Daily low
$63.70
Price at open
$64.20
52 Week High
$107.37
52 Week Low
$47.88
Market cap
3.5B
Dividend yield
0.00%
Volume
246
Avg. volume
601,829
P/E ratio
-87.46